Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Not yet disclosed by govt. Qualified | Qualified |
| 2 | Not yet disclosed by govt. Qualified | Qualified |
| 3 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: General |
| 4 | Not yet disclosed by govt. Qualified | Qualified MSE |
| 5 | Not yet disclosed by govt. Qualified | Qualified MSE, Category: General |
Tender Value
₹96.1 L
EMD Value
Exempted
Closing Date
3 Jul 2023, 9:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
RE22 ECHS
4884331
GEM/2023/B/3555898
Two Packet Bid
Insulin Lispro Biphasic injection I.P 25 PERCENT Insulin Lispro and 75 percent Insulin Lispro prota
30 days
Maharashtra; Pune
Item wise evaluation
PRODUCT
7 documents required · 7 mandatory
3 yrs
₹3
40%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Insulin Lispro Biphasic injection I.P 25 PERCENT Insulin Lispro and 75 percent Insulin Lispro protamine suspension | Pune | 1,500 | 30 days | |
| Inj Insulin Highly Purified human neutral 40 IU per ml 10 ml | Pune | 1,500 | 30 days | |
| Inj Insulin highly purified Isophane Human NPH 40 IU per ml 10 ml | Inj Human Insulin Anaogue Pune Glargine Recombinant D | 300 | 30 days | |
| Inj Human insulin anaogue Glargine Recombinant DNA orgin 450 IU per1.5 ml PFS Disposable Pen with 5 needles per pen | Pune | 1,500 | 30 days | |
| Inj Insulin Glulisine 100 iu per ml 3ml pfs | Pune | 150 | 30 days | - |
| Novapen needles | Pune | 12,000 | 30 days | |
| Insulin Lispro 100 IU per ml 3 ml PFS Inj Humolog rapid | Pune | 300 | 30 days | - |
| Tab Gliclazide MR 30 mg | Pune | 60,000 | 30 days | |
| Tab Gliclazide XR 60 mg | Pune | 60,000 | 30 days | |
| Tab Metformin 1000 mg Vildagliptin 50 mg | Pune | 60,000 | 30 days | |
| Tab Linagliptin 2.5 mg Metformin 500 mg | Pune | 15,000 | 30 days | |
| Tab Sitagliptin 50mg Metfromin 500 mg | Pune | 30,000 | 30 days | - |
| Tab Sitagliptin 50 mg Metformin 1000 mg | Pune | 45,000 | 30 days | |
| Tab Sitagliptin 100 mg | Pune | 90,000 | 30 days | - |
| Tab Vildagliptin 50 mg | Pune | 150,000 | 30 days | |
| Tab Pioglitazone Hydrochloride 15 mg | Pune | 60,000 | 30 days | |
| Tab Canagliflozin 100 mg | Pune | 6,000 | 30 days | |
| Tab Dapagliflozin 5 mg | Pune | 15,000 | 30 days | |
| Tab Dapagliflozin 10 mg | Pune | 30,000 | 30 days | |
| Tab Glimepiride 0.5 mg | Pune | 15,000 | 30 days | |
| Tab Glimepiride 3 mg | Pune | 3,000 | 30 days | - |
| Tab Gliclazide 40 mg | Pune | 30,000 | 30 days | |
| Tab Gliclazide 80 mg | Pune | 30,000 | 30 days | - |
| Tab Glipizide 5 mg Metformin 500 mg | Pune | 3,000 | 30 days | |
| Tab Linagliptin 2.5mg Metformin 1000 mg | Pune | 15,000 | 30 days | |
| Tab Sitagliptin 50 Mg | Pune | 90,000 | 30 days | |
| Tab Vildagliptin 50 mg Metformine 850 mg | Pune | 90,000 | 30 days | |
| Tab Tenegliptin 20 mg | Pune | 60,000 | 30 days | |
| Tab Saxagliptin 5 mg | Pune | 3,000 | 30 days | |
| Tab Acarbose 25 mg | Pune | 60,000 | 30 days | - |
| Tab Voglibose 0.3 mg BOQ Title RE22 ECHS | Pune | 60,000 | 30 days |
Exempted
31 Jul 2023
17 Jun 2023
3 Jul 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4884331.pdf
GEM_BID
specifications_2023-06-11-12-18-52_1994047a328494ae0e7fecfe1737bbb0.pdf
BOQ
boq_item_sample_file-1-1_2023-06-11-12-18-52_3e912e9a97ab2820f9a5f106b4bead25.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .